News | July 02, 2022
Ardelyx gets into $20 million financing agreement with HealthCare Royalty Partners
HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States
HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States
Lacosamide Injection is used to treat partial-onset seizures.
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
LoveDepot.com addresses this gap that is yawning in the market
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
Aurobindo Pharma Foundation endeavours to make a positive contribution to the underprivileged ommunities by supporting a wide range of socio-economic, educational, and health initiatives.
Bringing next-gen cannabinoid therapeutics to cancer patients
Glenmark is the first company in India to market the innovative FDC of Indacaterol
Doubling of median overall survival seen in QuANTUM-First results presented at EHA Presidential Symposium
The new subsidiary follows the recent announcement of Tetra's partnership with Cannvalate Pty Ltd for the performance of clinical trials of Tetra's drug candidates in Australia.
Subscribe To Our Newsletter & Stay Updated
